2016 Emerging Strategies for the 2016 US Point-of-Care/POC Lipid Testing Market

News provided by

Oct 21, 2015, 03:10 ET

DUBLIN, Oct. 21, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/6zgjfs/2016_emerging) has announced the addition of the "2016 Emerging Strategies for the US Point-of-Care/POC Lipid Testing Market" report to their offering.

This new 305-page report contains 22 tables, and provides a comprehensive analysis of thePOC lipid testing market, including trends, dynamics, size, growth, regulatory requirements, technological trends, competitive landscape, and emerging opportunities for instrument and consumable suppliers. This report will help diagnostic product suppliers develop effective business, R&D and marketing strategies for the global POC lipid testing market.

Rationale

The growing economic pressures on hospitals, coupled with advances in diagnostic technologies, intensifying competition among suppliers and physicians, and changing consumer demands are shifting diagnostic testing from hospitals and commercial laboratories closer to the patient.

Market Segmentation Analysis

- Review of three POC market segments, including their dynamics, trends, structure, size, growth and major suppliers.

Five-year test volume and reagent sales forecasts for lipid tests by market segment:

- Physician Offices/Group Practices
- Emergency Rooms
- Ambulatory Care Centers

Competitive Assessments

- Assessments of major POC suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, joint ventures, and new products in R&D.

Strategic Recommendations

- Specific opportunities for new instruments and reagent systems with potentially significant market appeal during the next five years.
- Design criteria for POC testing products.
- Alternative business expansion strategies.
- Potential market entry barriers and risks.

Companies Mentioned

- Abbott
- Affymetrix
- Beckman Coulter/Danaher
- Becton Dickinson
- bioMerieux
- Bio-Rad
- Cepheid
- Diamedix
- DiaSorin
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- ID Biomedical/GSK
- Kreatech/Leica
- Lonza
- Ortho-Clinical Diagnostics
- Qiagen
- Roche
- Scienion
- Sequenom
- SeraCare
- Siemens
- Takara Bio
- Thermo Fisher/Life Technology
- Wallac/PE
- Wako

For more information visit http://www.researchandmarkets.com/research/6zgjfs/2016_emerging